Stocks · Korea
067630
KOSDAQ
HLB Life Science
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
Returns and 52-week range
1W+15.29%
1M+59.13%
3M+34.57%
6M+5.55%
1Y+23.09%
YTD+3.85%
52W high5,330원
52W low1,608원
From 52W high-21.48%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 996억 | -202억 | -544억 | -20.2% |
| 2023 | 980억 | -245억 | -59억 | -25.0% |
| 2024 | 1,022억 | -248억 | 62억 | -24.3% |
| 2025 | 458억 | -220억 | -999억 | -48.1% |
| Quarterly | ||||
| 2024 4Q | 287억 | -68억 | -586억 | -23.9% |
| 2025 1Q | 275억 | -59억 | -572억 | -21.6% |
| 2025 2Q | 118억 | -67억 | -261억 | -56.5% |
| 2025 3Q | 136억 | -38억 | -368억 | -28.2% |
| 2025 4Q | -71억 | -56억 | 201억 | — |
| 2026 1Q | 152억 | -65억 | -78억 | -42.5% |
Company
Address: 경기도 화성시 동탄첨단산업1로 51-9 8층(영천동,엠타워지식산업센터)
Peers in the same sector
Recent filings
- 2026-08-13반기보고서 (2026.06)
- 2026-05-28주요사항보고서(전환사채권발행결정) Major
- 2026-05-15분기보고서 (2026.03)
- 2026-05-15주요사항보고서(영업정지) Major
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.